前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201702256878729815
整理番号：17A1970883
シアリル-Tnは生存低下に直面した筋層浸潤性膀胱癌基底および管腔サブタイプを同定する,循環腫瘍細胞と転移による表現されている【Powered by NICT】
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases
Lima Luis
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Lima Luis
(Institute for Research and Innovation in Health, University of Porto, Porto, Portugal)
,
Lima Luis
(Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal)
,
Lima Luis
(Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal)
,
Neves Manuel
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Neves Manuel
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Oliveira Marta I.
(International Iberian Nanotechnology Laboratory, Braga, Portugal)
,
Dieguez Lorena
(International Iberian Nanotechnology Laboratory, Braga, Portugal)
,
Freitas Rui
(Department of Urology, Portuguese Institute of Oncology, Porto, Portugal)
,
Azevedo Rita
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Azevedo Rita
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Gaiteiro Cristiana
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Gaiteiro Cristiana
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Soares Janine
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Ferreira Dylan
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Peixoto Andreia
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Peixoto Andreia
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Peixoto Andreia
(New Therapies Group, INEB-Institute for Biomedical Engineering, Porto, Portugal)
,
Peixoto Andreia
(Institute for Research and Innovation in Health, University of Porto, Porto, Portugal)
,
Fernandes Elisabete
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Fernandes Elisabete
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Fernandes Elisabete
(Institute for Research and Innovation in Health, University of Porto, Porto, Portugal)
,
Fernandes Elisabete
(Biomaterials for Multistage Drug and Cell Delivery, INEB-Institute for Biomedical Engineering, Porto, Portugal)
,
Montezuma Diana
(Department of Pathology, Portuguese Institute of Oncology of Porto, Porto, Portugal)
,
Tavares Ana
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Tavares Ana
(Department of Pathology, Portuguese Institute of Oncology of Porto, Porto, Portugal)
,
Ribeiro Ricardo
(Institute for Research and Innovation in Health, University of Porto, Porto, Portugal)
,
Ribeiro Ricardo
(Tumour and Microenvironment Interactions, INEB-Institute for Biomedical Engineering, Porto, Portugal)
,
Ribeiro Ricardo
(Laboratory of Genetics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal)
,
Ribeiro Ricardo
(Department of Clinical Pathology, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal)
,
Ribeiro Ricardo
(Molecular Oncology Group, Portuguese Institute of Oncology, Porto, Portugal)
,
Castro Ana
(Department of Medical Oncology, Porto Hospital Centre, Hospital of Santo Antonio, Porto, Portugal)
,
Oliveira Manuel
(Department of Urology, Porto Hospital Centre, Hospital of Santo Antonio, Porto, Portugal)
,
Fraga Avelino
(Department of Urology, Porto Hospital Centre, Hospital of Santo Antonio, Porto, Portugal)
,
Reis Celso A.
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Reis Celso A.
(Institute for Research and Innovation in Health, University of Porto, Porto, Portugal)
,
Reis Celso A.
(Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal)
,
Reis Celso A.
(Department of Pathology and Oncology, Faculty of Medicine, Porto University, Porto, Portugal)
,
Santos Lucio Lara
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Santos Lucio Lara
(Health School of University Fernando Pessoa, Porto, Portugal)
,
Santos Lucio Lara
(Department of Surgical Oncology, Portuguese Institute of Oncology, Porto, Portugal)
,
Ferreira Jose Alexandre
(Experimental Pathology and Therapeutics Group, Research Center, Portuguese Institute of Oncology, Porto, Portugal)
,
Ferreira Jose Alexandre
(Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal)
,
Ferreira Jose Alexandre
(International Iberian Nanotechnology Laboratory, Braga, Portugal)
,
Ferreira Jose Alexandre
(Institute for Research and Innovation in Health, University of Porto, Porto, Portugal)
,
Ferreira Jose Alexandre
(Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal)
,
Ferreira Jose Alexandre
(Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal)
資料名：
Urologic Oncology: Seminars and Original Investigations
(Urologic Oncology: Seminars and Original Investigations)
巻： 35 号： 12 ページ： 675.e1-675.e8 発行年： 2017年
JST資料番号： W3220A ISSN： 1078-1439 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： オランダ (NLD) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。